Fig. 8From: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinomaSchematic diagram of the underlying mechanisms up-regulation of Elafin by Sp1 enhances HCC metastasis and promotes Erlotinib resistance via EGFR/AKT signallingBack to article page